KVISTGAARD ANNE STAUDT,WEJSE PETER LANGBORG,DONOVAN SHARON,SIEGEL MARCIA H MONACO,COMSTOCK SARAH S
申请号：
IN201617002501
公开号：
IN201617002501A
申请日:
2016.01.22
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The disclosed invention provides mammalian milk osteopontin and/or an active truncation or active peptide thereof for improving immune responsiveness to an infectious disease in a mammal for example a human subject as well as enhancing the efficacy of vaccination for the prophylactic or therapeutic treatment of an infectious disease in mammals such as humans. The invention further provides a vaccine system for use in the prophylactic or therapeutic treatment of an infectious disease in a mammal comprising a vaccine and a mammalian milk osteopontin and/or an active truncation or active peptide thereof for oral administration to a mammal as well as methods of enhancing immune resistance to an infectious disease in a mammal by administration of a vaccine and a mammalian milk osteopontin and/or an active truncation thereof.
